PREDECT Publications

  1. List of PREDECT publications from 1st February 2011 until 31st December 2014
    Publications are available upon request

  2. Cell of origin links histotype spectrum to immune microenvironment diversity in non-small cell lung cancer driven by mutant Kras and loss of Lkb1
    Jan. 2017 - published in Cell Reports

  3. Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs
    Dec. 2016 - published in Biotechnology Journal

  4. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
    July 2016 - published in Nature: Scientific Reports

  5. Ellipsoid Segmentation Model for Analyzing Light-Attenuated 3D Confocal Image Stacks of Fluorescent Multi-Cellular Spheroids
    June 2016 - published in PLOS One

  6. MET expression during prostate cancer progression
    April 2016 - published in Oncotarget

  7. A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
    March 2016 - published in Cancer Cell

  8. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression.
    February 2016 - published in Biomaterials

  9. Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.
    January 2016 - published in PLOS One

  10. Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices.
    December 2015 - published in Scientific Reports

  11. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component
    May 2015 - published in Nucleic Acids Research

  12. High EMT Signature Score of Invasive Non- Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony- Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts
    April 2015 - published in PLOS One

  13. An ex vivo model to study hormone action in the human breast
    January 2015 - published in JoVE

  14. Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
    September 2014 - published in Biotechnology Journal

  15. Organotypic tissue cultures: a useful platform for evaluation of drug response in the intact tumour environment?
    September 2013 - Oral presentation at the DDResponse project Workshop on 3D culture models for radiation and cancer research, Rotterdam, Netherlands

  16. PREDECT developing advanced, complex in vitro 3D models for cancer target validation
    September 2013 - Oral presentation at the DDResponse project Workshop on 3D culture models for radiation and cancer research, Rotterdam, Netherlands

  17. Development of a Tissue Slice Culture Model for Prostate Cancer
    September 2013 - Oral presentation at the DDResponse project Workshop on 3D culture models for radiation and cancer research, Rotterdam, Netherlands

  18. Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
    April 2013 - Publication in Proceedings of the National Academy of Sciences

  19. Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast
    Schmid, et al. Manuscript published in Cancer Research

  20. Cancer cells cue the p53 response of cancer-associated fibroblasts to cisplatin
    June 2013 - Poster at the PCTRE, Malmö, Sweden

  21. Humanised in vitro co-culture demonstrates CRPC growth depends on adrenal androgens
    June 2013 - Poster at the PCTRE, Malmö, Sweden

  22. Establishment of a tissue-slice culture model for prostate cancer
  23. June 2013 - Poster at the PCTRE, Malmö, Sweden

  24. Establishment of a bioluminescent/fluorescent prostate cancer metastasis xenograft model
    June 2013 - Poster at the PCTRE, Malmö, Sweden

  25. Generation of 3D models that more faithfully represent prostate cancer tumour complexity
    June 2013 - Poster at the PCTRE, Malmö, Sweden

  26. Novel complex models for cancer target validation. What is the project (and why?) & key progress to date
  27. June 2013 - Oral presentation at the IMI Patient Focus Meeting, Brussels, Belgium

  28. Driving drugs to trial
    April 2013 - Interview in International Innovation

  29. Tumor growth characteristics of non-small cell lung cancer model LXFA 923 in humanized NSG mice
    April 2013 - Poster at the Oncotest symposium

  30. Progesterone/RANKL is a major regulatory axis in the human breast
    April 2013 - Publication in Science Translational Medicine

  31. Dual activity of abiraterone: CYP17 mediated androgen ablation and direct AR inhibition
    April 2013 - Poster at the AACR annual meeting, Washington, DC, USA

  32. Abiraterone is able to block AR activation induced by accumulating precursor hormones resulting from CYP17A1 inhibition
    March 2013 - Poster at the 28th annual EAU Congress, Milan, Italy

  33. Establishment and characterization of novel PSA-Cre;PtenLoxp/LoxP mouse prostate cancer models
    February-March 2013 - Poster at the Keystone meeting: PI3-Kinase and Interplay with other signaling pathways, Keystone, Colorado, USA

  34. Patient derived models for Breast Cancer
    January 2013 - Oral presentation at the Tumour Model meeting, London, UK

  35. Tissue Slice Culture: An ex-vivo tumour culture platform for pharmacodynamic analysis and dose response readouts
    November 2012 - Poster at the meeting Preclinical in vivo models to interrogate cancer biology, biomarkers and therapeutic response - Joint BACR/Oncology Section, Royal Society of Medicine

  36. The IMI PREDECT project: novel in vitro platforms for target validation
    November 2012 - Presentation at the 24th EORTC-NCI-AACR Symposium on ‘Molecular Targets and Cancer Therapeutics’, Dublin

  37. Establishment of a bioluminescent prostate cancer metastasis xenograft model
    October 2012 - Poster at the 20th ESUR (EAU Section of Urological Research) meeting, Strasbourg

  38. Establishment of a tissue‐slice culture model for prostate cancer
    October 2012 - Poster at the 20th ESUR (EAU Section of Urological Research) meeting, Strasbourg

  39. Creating Biomedical R&D leadership for Europe to benefit patients and society
    September 2012 - Presentation at the Oncology Cross Project Meeting at IMI, Brussels

  40. PREDECT – novel complex models for cancer target validation
    September 2012 - Poster at the QuiCConcept General meeting, Brussels

  41. Cancer cells cue the p53 response of cancer-associated fibroblasts (CAFs) to cisplatin
    September 2012 - Publication in Cancer Research

  42. Tissue Slice Culture of Breast Tumours
    May 2012 - Presentation at the FP7 DDR (DNA Damage Response) workshop, Rotterdam

  43. PREDECT: a large Industry-Academic Collaboration to Improve Target Validation Platforms
    March 2012 - Presentation at the Informa Life Science's Oncology Drug Discovery conference 2012, Berlin, Germany

  44. Molecular Characterization of the Tumour-Stroma Crosstalk Using a Novel 3D Co-Culture In Vitro Model
    March 2012 - Poster at the conference 3D Cell Culture Advanced Model Systems, Applications & Enabling Technologies

  45. in vitro co-culture model shows adrenal cells can drive prostate cancer growth in androgen deprived conditions
    February 2012 - Poster at the 16th Molecular Medicine Day Rotterdam, The Netherlands

  46. Establishment of a tissue-slice culture model for prostate cancer
    February 2012 - Poster at the 16th Molecular Medicine Day Rotterdam, The Netherlands

  47. Why Do Anticancer Drugs Fail in the Clinic
    February 2012 - Presentation in Cambridge

  48. Making a Public-Private Partnership
    January 2012 - Tekes interview, Helsinki

  49. Development of more predictive models - IMI perspectives
    September 2011 - Presentation at the Tekes event, Finland

  50. PREDECT: a new public-private IMI partnership to build cancer target validation models
    September 2011 - Poster at the Finnish Biotech partnering event, Finland

  51. PREDECT: a powerful new European Consortium addressing novel laboratory models for cancer target validation
    2011 - Press release

  52. PREDECT - New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours
    April 2011 - Factsheet in IMI newsletter

  53. Innovative Medicines Initiative EU consortium ‘PREDECT’ is seeking ambitious Postdoctoral Fellows
    March 2011 - Recruitment Ad in Nature

  54. Innovative Medicines Initiative EU consortium ‘PREDECT’ is seeking ambitious Postdoctoral Fellows
    March 2011 - Recruitment Ad in Nature Reviews of Cancer